Determinants of influenza vaccination timing
β Scribed by Byung Kwang Yoo; Kevin Frick
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 170 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.979
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
New guidelines recommend different influenza vaccination timing for different subpopulations due to the limited availability of flu shots (FS). This study's objectives are to develop a theoretical model to demonstrate why some individuals choose to receive an early FS while others choose a late FS and to empirically explore the determinants of vaccination timing. Empirical results generally supported the theoretical results. Individuals vary their FS timing in response to variations in perceived risks, chronic condition levels reflecting their risk of influenza infection, and opportunity costs, measured by the presence of medical care other than an FS. Copyright Β© 2005 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
We analyse the determinants of influenza vaccination take-up of Europeans above the age of 50 years using the first two waves of the Survey of Health, Ageing, and Retirement (SHARE). Using quality-of-care indicators, special emphasis is put on the measurement and the impact of physician quality. We
A cohort of 127 nursing home residents aged 60-98 years were vaccinated during the winter of 1985-86 with the A-Chile 1/83 (C), A-Philippines 2/82 (P), and B-USSR (B) commercial influenza vaccines. Before vaccination 40%, 23%, and 69% were susceptible to influenza Ac, Ap, and B, respectively [hemagg
Annual immunization against influenza is recommended for numerous individuals, but the antibody response to sequential vaccination has not been well characterized. Levels of hemagglutination-inhibition antibody were measured in adults given either two or three doses of trivalent influenza vaccine at
To assess the efficacy of influenza vaccination in immunocompromised adult liver transplant (LTx) recipients, the serum antibody responses of 61 of these patients and 35 liver cirrhosis patients with those of 45 of their healthy spouses were compared, after one and two vaccinations with a commercial